Coldstream Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,902
Closed -$319K 1228
2025
Q3
$319K Buy
29,902
+7,216
+32% +$70.8K ﹤0.01% 909
2025
Q2
$220K Buy
22,686
+8,644
+62% +$89.2K ﹤0.01% 1032
2025
Q1
$209K Sell
14,042
-4,297
-23% -$66.1K ﹤0.01% 989
2024
Q4
$274K Sell
18,339
-5,012
-21% -$81.7K 0.01% 864
2024
Q3
$415K Buy
23,351
+4,058
+21% +$84.1K 0.01% 681
2024
Q2
$399K Buy
19,293
+1,090
+6% +$21.7K 0.01% 646
2024
Q1
$342K Buy
18,203
+1,797
+11% +$30.8K 0.01% 712
2023
Q4
$237K Buy
+16,406
New +$223K 0.01% 815

Other funds holding OGN

Coldstream Capital Management's OGN Position: Q4 2025 in Review

Coldstream Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 29,902 shares — an estimated $319K sold.

Coldstream Capital Management first reported a position in OGN in Q4 2023 and held it in 8 quarters. The position peaked at $415K in Q3 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Coldstream Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 29,902 Organon & Co shares in Q4 2025, an estimated $319K.
  • Coldstream Capital Management first reported a position in Organon & Co in Q4 2023 and held it in 8 quarters.
  • Coldstream Capital Management's Organon & Co position peaked at $415K in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Coldstream Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.